FDA Inspection 1298982 - Chamindra Laverty - January 14, 2026

Record Details

This FDA Inspection record concerns Chamindra Laverty, with an inspection on January 14, 2026, issued by the Los Angeles District Office, covering human drugs.

Company: Chamindra Laverty
Inspection Date: January 14, 2026
Product Type: Human Drugs
Office: Los Angeles District Office
Person: Raman K. Kaushal (Issuing Officer)

View Company Profile

ID · 0fab053b-e8ea-4881-a837-dba917773ced

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1298982
FDA center: Human Drugs
Project area: Bioresearch Monitoring: Human Drugs
Outcome: Form 483 issued, view the record

FDA Citations

21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Chamindra Laverty

FDA Inspection

Chamindra LavertyJanuary 14, 2026